| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/16/2001 | EP0994948B1 Tgf beta rii receptor nucleic sequence, coded peptide, and uses |
| 05/16/2001 | EP0994706A4 Method and compositions for administering taxanes orally to human patients |
| 05/16/2001 | EP0810870B1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/16/2001 | EP0809489B1 Medicament form for the delivery of collagenase to wounds and process for the preparation thereof |
| 05/16/2001 | CN1295617A Variants of angiogenic factor vascular endothelial cell growth factor: VEGF |
| 05/16/2001 | CN1295616A Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them |
| 05/16/2001 | CN1295615A Human p51 genes and gene products thereof |
| 05/16/2001 | CN1295614A Modulator for function of receptor of TNF/NGF receptor family and other protein |
| 05/16/2001 | CN1295612A Mutant herpes simplex viruses and uses thereoe |
| 05/16/2001 | CN1295580A Method for producing mouse and haman endogenous vascular formation inhibition factor |
| 05/16/2001 | CN1295579A Therapeutic uses of keratinocyte growth factor-2 |
| 05/16/2001 | CN1295577A Method for searching physiologically active substances, process for producing these substances and drugs found by searching method |
| 05/16/2001 | CN1295484A Formulations for protection of PEG-interferon alpha conjugates |
| 05/16/2001 | CN1295482A Antagonists of the inflammatory mediator oncostatin M (OSM) |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1295126A Specific DNA sequence of oriental vole and its use |
| 05/16/2001 | CN1295081A Human tumor related nucleoprotein 24 and its code sequence |
| 05/16/2001 | CN1065913C Disinfect peptide-X gene structure, prodn tech. and use thereof |
| 05/16/2001 | CN1065911C Method for transferring human solid tumor Endostatin gene bifidobacteria |
| 05/16/2001 | CN1065875C Fibrillating cell growth factor-2 and analogue and its production method and use |
| 05/16/2001 | CN1065874C Novel peptides, preparation and use thereof |
| 05/16/2001 | CN1065768C Methods of treatment of motor neuron cliseases using members of BDNF/NT-3/NGF family of molecule |
| 05/15/2001 | US6232522 Non-human animal model for systemic lupus erythematosis |
| 05/15/2001 | US6232468 Antiinflammatory agent |
| 05/15/2001 | US6232460 Isolated nucleic acid molecule which encodes an SCP-1 mutein |
| 05/15/2001 | US6232459 Synaptojanin isoform |
| 05/15/2001 | US6232458 Proteins used in pharmaceutical human and veterinary applications; adapted to provide enhanced expression |
| 05/15/2001 | US6232454 Nucleic acid and amino acid sequences and use in diagnosis, treatment, and prevention of cancer and immune disorders |
| 05/15/2001 | US6232453 Gene encoding a polypeptide having pre-B cell growth-supporting ability |
| 05/15/2001 | US6232452 Autosomal dominant disorder of growths in many tissues and organs identified on chromosome 16 deletion mutations; use in disease diagnosis and screening; the gene may behave as a tumor suppressor |
| 05/15/2001 | US6232449 Persephin and related growth factors |
| 05/15/2001 | US6232446 Antibody to human tumor necrosis factor (tnf) binding protein which binds to extracellular domain of the c-terminal cysteine loop of the receptor; inhibit cytotoxic effect but not its binding to the receptor |
| 05/15/2001 | US6232445 Soluble MHC complexes and methods of use thereof |
| 05/15/2001 | US6232443 Useful markers in diagnosing and monitoring cancerous renal cells; detecting cell proliferative disorders |
| 05/15/2001 | US6232441 PIGR-1, a member of immunoglobulin gene superfamily |
| 05/15/2001 | US6232440 Of given amino acid sequence; screening for agonists and antagonists; use in diagnosis, prevention and treatment of cancer, immune disorders, and neurological disorders |
| 05/15/2001 | US6232438 Angiotensin converting enzyme inhibitors |
| 05/15/2001 | US6232342 Protease inhibitors |
| 05/15/2001 | US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 05/15/2001 | US6232300 Administering as hepatitis b viricide |
| 05/15/2001 | US6232295 Cell-specific contrast agent and gene delivery vehicles |
| 05/15/2001 | US6232293 Administering tryptophan-tryptophan, tryptophan-tyrosine, or tyrosine-tryptophan dipeptide coupled to protein or peptide carrier as antiinflammatory agent |
| 05/15/2001 | US6232292 3-dehydroquinate synthase |
| 05/15/2001 | US6232290 Cyclic hexapeptides with antimicrobial activity |
| 05/15/2001 | US6232289 Method of treating interstitial cytitis with recombinant heparin-binding epidermal growth factor-like growth factor (HB-EGF) |
| 05/15/2001 | US6232288 Composition for improving pancreatic function |
| 05/15/2001 | US6232287 Peptide targets prostate gland; diagnosis; drug delivery; biochemical conjugation |
| 05/15/2001 | US6232286 Methods of stimulating mitogenesis in glial cells using glial mitogenic factors |
| 05/15/2001 | US6232119 Immortalized human fetal neuronal cell line |
| 05/15/2001 | US6232118 Nucleic acid encoding a protein of defined amino acid sequence; recombinant cell culture production; diagnosis; probes; treatment of parkinson's disease and other nervous system disorders with reduced side effects; gene therapy |
| 05/15/2001 | US6232110 Coding sequence for protein phosphatase methylesterase, recombinant DNA molecules and methods |
| 05/15/2001 | US6232107 Nucleotide sequence coding green fluorescent protein; for use in diagnosis of microorganism infection |
| 05/15/2001 | US6232100 Nucleotide sequence which codes for hormone-regulating neuropeptide; diagnosis and therapy of nervous system disorders; probes; primers |
| 05/15/2001 | US6232098 Kunitz domain polypeptide and materials and methods for making it |
| 05/15/2001 | US6232097 Nucleotide sequences coding enzymatic polypeptide; prevent bacterial infection; wound healing agents; for vaccine development |
| 05/15/2001 | US6232096 Flea serine protease nucleic acid molecules and uses thereof |
| 05/15/2001 | US6232088 Administering hydrolase enzyme; deactivating cellular adhesion molecules |
| 05/15/2001 | US6232086 Method for detecting cancer cells |
| 05/15/2001 | US6232084 Competitive binding |
| 05/15/2001 | US6232081 Complexing with slimb protein |
| 05/15/2001 | US6232080 Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use |
| 05/15/2001 | US6232077 Genetic engineering and expression; cancer diagnosis |
| 05/15/2001 | US6232071 Tenascin-C nucleic acid ligands |
| 05/15/2001 | US6232064 Fibrosis and atherosclerosis determination |
| 05/15/2001 | US6232061 Detecting hybridization signals with probes; genetic engineering; identifying dna sequences that code for evolutionary conserved amino acid sequences |
| 05/15/2001 | US6231882 Mixed micellar delivery system and method of preparation |
| 05/15/2001 | US6231869 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 05/15/2001 | US6231862 Purified new epididymal forward motility protein and a process for the isolation of the said epididymal forward motility protein useful as a fertility prometer/blocker |
| 05/15/2001 | US6231856 Methods and compositions for treatment of autoimmune diseases |
| 05/15/2001 | US6231855 Side effect reduction |
| 05/15/2001 | US6231854 Methioninase formulations and use in diagnostic methods |
| 05/15/2001 | US6231853 Human glutathione peroxidase-6 |
| 05/15/2001 | US6231851 Methods and compositions for the dry powder formulation of interferons |
| 05/15/2001 | US6231850 Canine interleukin 12 |
| 05/15/2001 | US6231536 Method and compositions for treatments of cancers |
| 05/15/2001 | CA2310845C Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 05/15/2001 | CA2238978C Retroviral protease inhibiting compounds |
| 05/15/2001 | CA2195975C An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides |
| 05/15/2001 | CA2183268C Bispecific molecules having clinical utilities |
| 05/15/2001 | CA2180011C Botulinum toxins for treating sweating |
| 05/15/2001 | CA2158054C Conjugates of proteins and bifunctional ligands |
| 05/15/2001 | CA2072355C Fibrin sealant delivery method |
| 05/15/2001 | CA2041638C Recombinant polynucleotide constructs suitable for providing secretion of pai-2 |
| 05/15/2001 | CA1341231C Primary biliary cirrhosis autoantigen |
| 05/15/2001 | CA1341229C Procoagulant proteins derived from factor viii: c |
| 05/15/2001 | CA1341228C Expression of protein c |
| 05/15/2001 | CA1341227C Human transforming growth factor alpha |
| 05/10/2001 | WO2001033221A1 Axor35, a g-protein coupled receptor |
| 05/10/2001 | WO2001032926A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | WO2001032925A1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 05/10/2001 | WO2001032923A1 Antisense inhibition of pi3 kinase p55 gamma expression |
| 05/10/2001 | WO2001032920A2 Agents implicated in endometriosis |
| 05/10/2001 | WO2001032910A2 27 human secreted proteins |
| 05/10/2001 | WO2001032905A1 Process for producing a product containing antihypertensive tripeptides |
| 05/10/2001 | WO2001032900A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 05/10/2001 | WO2001032891A2 Human lipase |
| 05/10/2001 | WO2001032888A2 Human transferase molecules |
| 05/10/2001 | WO2001032885A2 Human lipase |
| 05/10/2001 | WO2001032878A2 A novel polypeptide hormone phosphatonin |
| 05/10/2001 | WO2001032875A1 Torsin c nucleic acids and polypeptides |